Summary of Product Characteristics
last updated on the eMC:
17/03/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 17/03/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 6. 5 - Nature and Contents of Container
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 05-Mar-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to section 6.5
To register an additional 2-piece Child Resistant Cap container closure system.
The wadding material used with Benylin Children's Chesty Coughs has been changed from a PE wad to a PVDC wad.
|
|
Updated on 20/04/2009 and displayed until 17/03/2010
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.2 - Posology and method of administration
-
Change to section 4.3 - Contraindications
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 31-Mar-2009 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
Update to Childrens Cough and Cold medicinal products as requested by the MHRA:
http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON038908
|
|
Updated on 17/04/2008 and displayed until 20/04/2009
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 04/2008 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to MA as a result of integration.
|
|
Updated on 03/04/2008 and displayed until 17/04/2008
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 03/2008 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to MA as a result of integration
|
|
Updated on 29/09/2004 and displayed until 03/04/2008
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 26/09/2003 and displayed until 29/09/2004
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and Method of Administration
|
|
Updated on 26/09/2002 and displayed until 26/09/2003
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 16/09/2002 and displayed until 26/09/2002
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 24/08/2001 and displayed until 16/09/2002
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|